Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Use of a Histone Deacetylase Inhibitor to Increase The Entry of an Adenoviral Agent Into a Cell

  • Read more about Use of a Histone Deacetylase Inhibitor to Increase The Entry of an Adenoviral Agent Into a Cell
US Application 60/315,008
Filed on 2001-08-24

Phytoestrogenic Isoflavone Compositions, Their Preparation, And Use Thereof For Protection Against Treatment of Radiation Injury

  • Read more about Phytoestrogenic Isoflavone Compositions, Their Preparation, And Use Thereof For Protection Against Treatment of Radiation Injury
US Application 60/223,734
Filed on 2000-08-08

Beta-Glucuronidase-Activated Prodrugs of O6-Alkylguanine-DNA Alkyltransferase Inactivators

  • Read more about Beta-Glucuronidase-Activated Prodrugs of O6-Alkylguanine-DNA Alkyltransferase Inactivators
US Application 60/330,729
Filed on 2001-10-29

Structure Determination of Material Using Electron Microscopy

  • Read more about Structure Determination of Material Using Electron Microscopy
US Application 60/285,819
Filed on 2001-04-23

Identification of a Cell Surface Receptor For Papillomaviruses

  • Read more about Identification of a Cell Surface Receptor For Papillomaviruses
US Application 60/287,776
Filed on 2001-05-01

HTLV-1 p30II AND p12 PROTEINS AS THERAPEUTIC TARGETS IN HTLC-1 INFECTED INDIVIDUALS

  • Read more about HTLV-1 p30II AND p12 PROTEINS AS THERAPEUTIC TARGETS IN HTLC-1 INFECTED INDIVIDUALS
US Application 60/404,580
Filed on 2002-08-19

Maxp1

  • Read more about Maxp1
US Application 60/323,274
Filed on 2001-09-19

Tandem Repeat Markers

  • Read more about Tandem Repeat Markers
US Application 60/327,189
Filed on 2001-10-04

Human Foamy Virus (HFV) Reverse Transcriptase is Higly Active And Processive

  • Read more about Human Foamy Virus (HFV) Reverse Transcriptase is Higly Active And Processive
US Application 60/292,994
Filed on 2001-05-22

Method of Promoting Engraftment of a Donor Transplant in a Recipient Host

  • Read more about Method of Promoting Engraftment of a Donor Transplant in a Recipient Host
US Application 60/302,258
Filed on 2001-06-29

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 188
  • Page 189
  • Page 190
  • Page 191
  • Page 192
  • Page 193
  • Page 194
  • Page 195
  • Page 196
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health